Leishmaniasis is a group of infectious neglected tropical diseases caused by more than 20
pathogenic species of Leishmania sp. Due to the limitations of the current treatments …

The presence of an RNA virus in a South American subgenus of the Leishmania parasite,
L.(Viannia), was detected several decades ago but its role in leishmanial virulence and …

Promastigotes of Leishmania (Viannia) panamensis were successfully transfected with p6. 5-
egfp to express green fluorescent protein. The transfectants remained infective to …

Leishmaniases are diseases caused by protozoa of the genus Leishmania that affect more
than 20 million people in the world. The initial phase of the infection is fundamental for either …

In Colombia, most cases of human cutaneous leishmaniasis are caused by Leishmania
(Viannia) panamensis. Interestingly, up to 30% of the exposed population do not suffer from …

A primate model of leishmaniasis was developed with the objective of future vaccine testing.
Lesion development and immunological parameters were studied upon primary and …

Aims Leishmaniasis is considered a disease with multiple clinical/immunopathological
characteristics, depending on the immunity of the host and the species of the parasite. In …

Cutaneous Leishmaniasis caused by Leishmania guyanensis parasites is endemic in the
North-East South America. There is, however, little information available concerning L …

A leishmaniose é considerada uma doença espectral com múltiplas características clínicas
e imunopatológicas em humanos, dependendo das características imunogenéticas do …

Leishmania (Viannia) panamensis HSJD-1 strain, confirming that it only reacted with
monoclonal antibodies (mAbs) for L.(L.) amazonensis and did not react with reference …